Oxford Biomedica: Biotech and Money Investival Showcase (Biotech and Money Investival Showcase, Oxford Biomedica) - Nov 19, 2016 - Anticipated initiation of pivotal P2b/P3 trial in Stargardt disease by the end of 2018
Anticipated new P2/3 trial • Inherited Retinal Dystrophy • Ophthalmology
|